Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares Outstanding
Ratios

Enanta Pharmaceuticals (ENTA) Shares Issued (2016 - 2025)

Historic Shares Issued for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q4 2025 value amounting to $69.9 million.

  • Enanta Pharmaceuticals' Shares Issued rose 7431276.6% to $69.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $70.0 million, marking a year-over-year increase of 2894522.82%. This contributed to the annual value of $145000.0 for FY2025, which is 136.05% down from last year.
  • As of Q4 2025, Enanta Pharmaceuticals' Shares Issued stood at $69.9 million, which was up 7431276.6% from $51000.0 recorded in Q3 2025.
  • Enanta Pharmaceuticals' Shares Issued's 5-year high stood at $69.9 million during Q4 2025, with a 5-year trough of $28000.0 in Q2 2024.
  • For the 5-year period, Enanta Pharmaceuticals' Shares Issued averaged around $6.0 million, with its median value being $912500.0 (2021).
  • Its Shares Issued has fluctuated over the past 5 years, first plummeted by 9514.56% in 2023, then surged by 7431276.6% in 2025.
  • Quarter analysis of 5 years shows Enanta Pharmaceuticals' Shares Issued stood at $10.4 million in 2021, then tumbled by 89.18% to $1.1 million in 2022, then tumbled by 82.24% to $200000.0 in 2023, then tumbled by 53.0% to $94000.0 in 2024, then surged by 74312.77% to $69.9 million in 2025.
  • Its last three reported values are $69.9 million in Q4 2025, $51000.0 for Q3 2025, and $94000.0 during Q4 2024.